Abstract
Background and Objectives Understanding risk factors and spatial variation of risk may provide insights into the pathological mechanism of motor neuron disease (MND). Socioeconomic status (SES) has been hypothesised as a risk factor, but results from previous studies are inconsistent. No spatial epidemiology studies examining geographic clustering of MND have been performed in Scotland to date. We investigated the effect of SES and geography on MND risk in Scotland using the highly curated and nationally representative Scottish MND Register (CARE-MND) that has over 95% case ascertainment.
Methods Patients on the Scottish Clinical Audit Research Evaluation for Motor Neurone Disease platform, with date of diagnosis between 01 Jan 2015 and 28 Feb 2021 were included and geocoded with data zones using their residence at diagnosis. Indirectly standardised incidence ratio (SIR) accounting for age and sex was calculated for each health board. Poisson regression was used to examine the effect of SES on MND risk, adjusted for age and sex of population at risk. Geographic clustering was assessed using global Moran’s Index, Bayesian conditional autoregressive models and SaTScan software.
Results Among 1149 patients included, 1126 (98%) were successfully geocoded. Significantly lower SIR was shown in Highland (0.60, 95% CI 0.44 – 0.80, p<0.001). After adjusting for age and sex in Poisson regression, there was no significant effect of SES on MND risk. Moran’s Index indicated a weak but significant spatial autocorrelation (I=0.017, p=0.008). However, risk maps using Bayesian modelling showed a relatively homogeneous distribution without distinct patterns across Scotland. Similarly, SaTScan did not detect any significant cluster of high or low risks.
Discussion Our findings support the notion that MND risk is mostly random-distributed and independent of SES in Scotland. Our results are generalizable to other MND populations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Y.T. Chang and P.K.A. Kearns have received funding from Rowling Scholar Fellowship Fund of the Anne Rowling Regenerative Neurology Clinic. P.K.A. Kearns is funded by an ECAT/Wellcome PhD Studentship. S. Chandran received grant from Dementia Research Institute.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approvals for the CARE-MND were granted by the Scotland A Research Ethics Committee 15/SS/0126.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data from the CARE-MND platform in this study are not publicly available due to patient identifiable information. Qualified investigators may request access to anonymized data for a reasonable purpose.
